Chambers and Partners has published the 2022 edition of the Chambers Europe Guide, in which, based on opinions of clients and other lawyers, the leading lawyers and law firms in Europe are identified and classified and Faus & Moliner appears once again as the leading law firm in pharmaceutical law in Spain.
Those consulted by the Chambers & Partners team remark as the main strength of the firm its leadership in regulatory matters on the life sciences industry as well as on pricing and reimbursement. Likewise, they highlight its wide experience on administrative appeals against public procurement or pricing decisions and in product liability cases, and praise the firm’s “agile team and rigorous advice“.
Information published by Chambers & Partners on its webpage:
What the team is known for prestigious Barcelona-based boutique with a stand-out reputation in regulatory issues relating to the life sciences market. It is regularly retained by key players from the pharmaceutical and medical devices industries to advise on a range of matters that entail interaction with Spain’s life sciences sector regulators, including applications for marketing authorisations or negotiations relating to the pricing and potential reimbursement of medical products. The firm advises on administrative appeals against public procurement or pricing decisions. It defends leading life sciences companies in product liability cases. The firm also earns praise for its advice on the drafting and negotiation of commercial agreements between life sciences companies.
Strengths clients say that Faus & Moliner is “the best law firm specialised in the pharmaceuticals industry” and appreciate their lawyers being “incredibly pragmatic, knowledgeable and happy to assist on a wide breadth of matters.”
Jordi Faus is often identified as the top lawyer in Spain for life sciences regulatory issues. “He provides a combination of knowledge, level of service, expertise and value for money that has no equal at the moment in Spain,” states one client. “He is a brilliant lawyer and a real trusted partner for his clients,” reports another interviewee, while a third source says: “He has that practical knowledge of the market and the companies in terms of what they are doing, and he knows what the regulator thinks.”
Xavier Moliner has standout experience in the defence of sensitive product liability claims brought against major life sciences companies. He also advises on procurement disputes. He is known among market commentators as an important member of the Faus & Moliner team.